- 1. Ora Testryl
- (UMLS (NCI) C0733926) Ora-Testryl =Steroid; Pharmacologic Substance; Hormone
| - 29. oral facial reconstruction
- [ ] (UMLS (CSP) C1537037) =Therapeutic or Preventive Procedure ;
|
- 2. Oral
- [Oral ( HL7V3.0 )] (UMLS (HL7) C0205531) =Functional Concept =drug administration route;
RouteBySite =Chew, oral;
Dissolve, oral;
Inhalation, intrapulmonary;
Rinse, oral;
Swallow, oral;
Topical application, oral | - 30. oral facial restoration
- [procedures used to reconstruct, restore, or improve, damaged, or missing orofacial structures. ( CSP )] (UMLS (CSP) C0597135) =Therapeutic or Preventive Procedure ;
=plastic surgery;
|
- 3. oral
- [By or having to do with the mouth. ( NCI )] (UMLS (NCI) C0442027) =Spatial Concept
| - 31. oral facial restoration material
- [materials contained in temporary or permanent cleft palate prostheses and oral facial restoration; may be an implant, biomaterial or prosthetic device. ( CSP )] (UMLS (CSP) C0597136) =Biomedical or Dental Material ;
=biomaterial;
|
- 4. Oral & Maxillofacial Surgery
- (UMLS (HL7) C1555793) =Professional or Occupational Group =Allopathic & Osteopathic Physicians;
| - 32. Oral Fluorouracil-Uracil
- [A formulated therapeutic oral agent consisting of a combination of tetrahydrofuranyl-5-fluorouracil and uracil (1:4). Tetrahydrofuranyl-5-fluorouracil, the congener prodrug of 5-fluorouracil (5-FU), is metabolized to 5-FU either by hepatic cytochrome P-450 enzymes or by ubiquitous cytosolic enzymes in the body. Because of its higher concentration in the combination, uracil saturates the uracil-reducing enzymatic activity of dihydropyrimidine dehydrogenase, thereby inhibiting first-pass dihydropyrimidine dehydrogenase-mediated hepatic metabolism of the uracil analogue, 5-FU, and permitting prolonged concentration of 5-FU in tumor tissue. 5-FU inhibits the enzyme thymidylate synthase, thereby decreases available thymidine nucleotide. As a result, DNA synthesis is inhibited and tumor cell proliferation is blocked. ( NCI )] (UMLS (NCI) C1446539) Tegafur-Uracil;
UFT;
Uracil and Ftorafur;
Uracil and Tegafur;
Uracil and Tetrahydrofuranyl-5-Fluorouracil;
Uracil/Tegafur (UFT) =Organic Chemical; Pharmacologic Substance |
- 5. oral administration
- [route of drug or nutrient intake via the mouth. ( CSP )] (UMLS (CSP) C0001563) =Therapeutic or Preventive Procedure ;
| - 33. oral health service
- [A clinical Invoice Grouping consisting of one or more oral health services. Billing for these service(s) are supported by multiple clinical billable events (acts). All items in the Invoice Grouping must be adjudicated together to be acceptable to the Adjudicator. ( HL7V3.0 )] (UMLS (HL7) C1552565) =Intellectual Product ;
=ActInvoiceRootGroupCode;
|
- 6. oral airflow measurement
- [ ] (UMLS (CSP) C0599319) =Diagnostic Procedure ;
| - 34. Oral Mucosa Lobular Capillary Hemangioma
- [A lobular hemangioma arising from the oral mucosa. ( NCI )] (UMLS (NCI) C0267019) =Disease or Syndrome
|
- 7. Oral and Maxillofacial Pathology
- [The specialty of dentistry and discipline of pathology that deals with the nature, identification, and management of diseases affecting the oral and maxillofacial regions. It is a science that investigates the causes, processes, and effects of these diseases. The practice of oral and maxillofacial pathology includes research and diagnosis of diseases using clinical, radiographic, microscopic, biochemical, or other examinations.Source: Council on Dental Education and Licensure, American Dental Association ( HL7V3.0 )] (UMLS (HL7) C1555930) =Intellectual Product =Dentist;
| - 35. Oral Pathology
- [A dental specialty concerned with pathology of the oral cavity. ( MSH )] (UMLS (NCI) C0030668) =Biomedical Occupation or Discipline
|
- 8. Oral and Maxillofacial Radiology
- [The specialty of dentistry and discipline of radiology concerned with the production and interpretation of images and data produced by all modalities of radiant energy that are used for the diagnosis and management of diseases, disorders and conditions of the oral and maxillofacial region.Source: Council on Dental Education and Licensure, American Dental Association ( HL7V3.0 )] (UMLS (HL7) C1555931) =Intellectual Product =Dentist;
| - 36. oral pharyngeal
- [region of the stomatognathic system and the gastrointestinal system that extends from the lips, past the soft palate and to the epiglottis; also refers to the specific anatomical portion of pharynx, oropharynx, that is below the soft palate and above the epiglottis and is continuous with the mouth. ( CSP )] (UMLS (CSP) C0521367) =Body Location or Region =head;
pharynx;
Body Part;
=Head and Neck, Salivary Glands;
Buccal Cavity;
dental structure |
- 9. Oral and Maxillofacial Surgery
- [The specialty of dentistry which includes the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.Source: Council on Dental Education and Licensure, American Dental Association ( HL7V3.0 )] (UMLS (HL7) C1552440) =Manufactured Object; Health Care Related Organization =Clinic/Center;
| - 37. oral pharyngeal disorder
- [impairment of health or a condition of abnormal functioning of a region of the pharynx that is below the soft palate and above the epiglottis and is continuous with the mouth. ( CSP )] (UMLS (CSP) C0553694) =Disease or Syndrome =Gastrointestinal Diseases;
=Neoplasm of Oropharynx;
pharyngitis;
Diseases of the salivary glands;
stomatitis;
oral pharyngeal hyperplasia |
- 10. Oral and Maxillofacial Surgery
- [The specialty of dentistry which includes the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.Source: Council on Dental Education and Licensure, American Dental Association ( HL7V3.0 )] (UMLS (HL7) C1555932) =Professional or Occupational Group =Dentist;
| - 38. oral pharyngeal disorder diagnosis
- [determination of an impairment of health or a condition of abnormal functioning of oral pharynx based on symptoms, medical history, risk factors, and clinical tests; oral pharyngeal refers to the region of the body between the lips and the oropharynx, which is pharynx below the soft palate and above the epiglottis. ( CSP )] (UMLS (CSP) C0178783) =Diagnostic Procedure =gastrointestinal disorder diagnosis;
=dental disorder diagnosis;
|
- 11. oral bacteria
- [see RTs for specific organisms. ( CSP )] (UMLS (CSP) C0597134) =Bacterium ;
=bacteria characteristic;
| - 39. oral pharyngeal hyperplasia
- [increase in the number of cells in the oral pharynx without tumor formation; it differs from hypertrophy, which is an increase in bulk without an increase in the number of oral pharynx cells; oral pharyngeal refers to the region of the body between the lips and the oropharynx, which is pharynx below the soft palate and above the epiglottis. ( CSP )] (UMLS (CSP) C0597138) =Disease or Syndrome ;
=hyperplasia;
oral pharyngeal disorder =gingiva hyperplasia;
Leukokeratosis of Oral Mucosa |
- 12. oral behavior
- [any behaviors involving the mouth; includes the response of the mammalian infant to draw milk from the breast, sucking on inanimate objects, nail biting, thumb sucking, chewing, etc. ( CSP )] (UMLS (CSP) C0178781) =Individual Behavior =behavior;
=eating;
chewing | - 40. oral pharyngeal surgery
- [procedures performed on the oral pharyngeal areas, used in the treatment of disease, injuries, or deformities; oral pharyngeal refers to the region of the body between the lips and the oropharynx, which is pharynx below the soft palate and above the epiglottis, including dental structures. ( CSP )] (UMLS (CSP) C0597139) =Therapeutic or Preventive Procedure ;
=gastrointestinal surgery;
=Extraction of Tooth;
|
- 13. ORAL BISPHOSPHONATES
- [ ] (UMLS (ICD9CM) C1955565) =Injury or Poisoning
| - 41. Oral Prosthesis
- (UMLS (NCI) C0935659) =Medical Device
|
- 14. Oral Cancer Prevention
- (UMLS (NCI) C0678094) =Therapeutic or Preventive Procedure
| - 42. oral pulvinar nucleus
- [ ] (UMLS (CSP) C0262299) =Body Part, Organ, or Organ Component
|
- 15. Oral Cavity and Lip Precancerous Condition
- (UMLS (NCI) C1335125) Oral Cavity and Lip Premalignant Condition =Disease or Syndrome ;
| - 43. oral reconstruction
- [ ] (UMLS (CSP) C1537038) =Therapeutic or Preventive Procedure ;
|
- 16. Oral Cavity Benign Granular Cell Neoplasm
- (UMLS (NCI) C1335117) Oral Cavity Benign Granular Cell Tumor =Neoplastic Process ;
| - 44. oral rehydration therapy
- [ ] (UMLS (CSP) C0029168) =Therapeutic or Preventive Procedure ;
|
- 17. ORAL CAVITY DX PROC NEC
- [ ] (UMLS (ICD9CM) C0176436) =Diagnostic Procedure
| - 45. ORAL SOFT TISSUE DIS NEC
- [ ] (UMLS (ICD9CM) C0029498) =Disease or Syndrome
|
- 18. Oral Cavity Finding
- (UMLS (NCI) C0455788) =Finding
| - 46. oral surgeon
- [A dentist with special training in surgery of the mouth and jaw. ( NCI )] (UMLS (NCI) C0260272) =Professional or Occupational Group
|
- 19. ORAL CAVITY OPS NEC
- [ ] (UMLS (ICD9CM) C0176453) =Therapeutic or Preventive Procedure
| - 47. Oral Surgery
- [A dental specialty concerned with the diagnosis and surgical treatment of disease, injuries, and defects of the human oral and maxillofacial region. ( MSH )] (UMLS (NCI) C0038908) =Biomedical Occupation or Discipline
|
- 20. Oral Cavity Submucous Fibrosis
- (UMLS (NCI) C0029171) =Disease or Syndrome ;
| - 48. oral tolerance
- [state of immunologic unresponsiveness induced by the prior ingestion of antigen. ( CSP )] (UMLS (CSP) C0597140) =Organism Attribute ;
=immune tolerance/unresponsiveness;
|
- 21. oral cholecystography
- [ ] (UMLS (CSP) C0203079) =Diagnostic Procedure
| - 49. oral tolerization
- [ ] (UMLS (CSP) C0599028) =Organism Function ;
|
- 22. Oral Complications of Cancer and Cancer Therapy
- (UMLS (NCI) C1321873) =Finding ;
| - 50. Oramorph SR
- (UMLS (NCI) C0700785) =Organic Chemical; Pharmacologic Substance
|
- 23. Oral Complications of Chemotherapy and Head and Neck Radiation
- (UMLS (NCI) C0879594) =Injury or Poisoning
| - 51. ORANGE
- [The hue of that portion of the visible spectrum lying between red and yellow, evoked in the human observer by radiant energy with wavelengths of approximately 590 to 630 nanometers; any of a group of colors between red and yellow in hue, of medium lightness and moderate saturation. ( NCI )] (UMLS (NCI) C1313858) =Qualitative Concept; ;
|
- 24. Oral Contraceptive
- [Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. ( MSH )] (UMLS (NCI) C0009905) =Pharmacologic Substance ;
| - 52. Orange Juice
- (UMLS (NCI) C0452458) =Food =Unclassified Ingredients;
Inactive Ingredient Preparations =COMPLEAT MODIFIED LIQUID;
COMPLEAT MODIFIED LIQUID (CLOSED SYSTEM);
COMPLEAT REGULAR FORMULA LIQUID;
COMPLEAT REGULAR LIQUID (CLOSED SYSTEM);
|
- 25. Oral Contraceptive Preparation
- [Orally administered synthetic sex hormones with contraceptive activity. The oral contraceptive preparation contains a combination of an estrogen, such as ethinyl estradiol, and a progestagen, such as levonorgestrel or norethidrone. The oral contraceptive prevents pregnancy by preventing ovulation and by inducing endometrial and cervical changes undesirable for fertilization and implantation. ( NCI )] (UMLS (NCI) C0009906) =Pharmacologic Substance ;
| - 53. orangutan
- [The single species of orangutan belonging to the HOMINIDAE family and found only in lowland forests of Sumatra and Borneo. Among the PRIMATES, the orangutan is second in size only to the gorilla (GORILLA GORILLA). ( MSH )] (UMLS (CSP) C0032638) =Mammal
|
- 26. Oral Contraceptives
- (UMLS (HL7) C1548892) =Health Care Activity =Consent Type;
| - 54. Orap
- (UMLS (NCI) C0591918) =Organic Chemical; Pharmacologic Substance ;
|
- 27. Oral Dosage Form
- [Different formulations for oral administration include solutions, suspensions, capsules, compressed tablets, coated medications and controlled release dosage forms. The availability of a drug for absorption is maximal in solutions and decreases in descending order with suspensions, capsules, compressed tablets, and coated tablets, respectively. ( NCI )] (UMLS (NCI) C1272919) Oral Dose Form;
=Biomedical or Dental Material ;
| - 55. Orasone
- (UMLS (NCI) C0728771) =Steroid; Pharmacologic Substance ;
|
- 28. oral facial pain
- [pain in the oral and/or facial regions; associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. ( CSP )] (UMLS (CSP) C0178782) =Sign or Symptom =pain;
=Fothergill's neuralgia;
| |
home
